Multiple Sclerosis Trial, Recruiting NCT06195800 Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06195800
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with an immune-mediated neurological disease (a condition where the immune system attacks the nervous system), based on recognised diagnostic standards, or people diagnosed with relapsing-remitting multiple sclerosis (a form of MS where symptoms come and go)
  • People who are being treated with a stem cell transplant using their own stem cells, or people being treated with a high-strength medication used to manage their neurological condition
  • People who are willing to provide blood or biological samples and attend check-up assessments throughout the follow-up period
  • People who can understand English and are able to give their formal agreement to take part in the trial

Who may not be able to join:

  • People who are not able to give their formal, informed agreement to participate in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gavin Brittain, MBBS, MRCP, Sheffield Teaching Hospitals NHS Foundation Trust and The University of Sheffield

Phone: +44114 271 1900

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Registry
ClinicalTrials.gov
Start date
9 August 2023
Est. completion
9 August 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Quantitatively and qualitatively characterise the immune profile of the stem cells, blood, cerebrospinal fluid (CSF) and the microbiome pre and post treatment.; Perform single cell RNA sequencing (scRNA-Seq) on paired CSF and blood pre and post treatment.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov